VEGFA and retinal ischemia: Studies have demonstrated that anti-VEGF treatment could not only reduce autophagy and apoptosis rates and activate ischemia-damaged microglia to protect the retinal ganglion cells and bipolar cells, further normalize peripheral cells, stabilize the basement membrane, but also reopen closed retinal vessels, prevent the progression of vessel closure, and improve retinal ischemia (26, 27).